
The Food and Drug Administration announced Friday that it is moving ahead with a safety review of the abortion pill mifepristone, responding to months of pressure from anti-abortion lawmakers and activists who have urged the federal government to take a closer look at the drug’s oversight and availability. According to an administration official, the review…
Read More »

